MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Wearing-off fluctuations"

  • 2024 International Congress

    The Differences in the Perception of Parkinson’s Disease-related Motor Complications between Patients and Physicians

    T. Tezuka, R. Okochi, Y. Sakai, T. Nukariya, S. Okusa, Y. Nihei, J. Nakahara, M. Seki (Tokyo, Japan)

    Objective: This study aimed to evaluate the differences in the perception of Parkinson’s disease (PD)-related motor complications by utilizing questionnaires answered by both PD patients…
  • 2024 International Congress

    Exploring the Influence of Gastrointestinal Symptoms on Non-Motor Fluctuations in Parkinson’s Disease: Insights from the ReMePark-2, a Mexican Cohort

    A. Cervantes-Arriaga, AJ. Hernández Medrano, AL. Guerra-Anzaldo, A. Domínguez-García, DP. Romero-Terán, G. Rivera-Monroy, KI. Sánchez-Ramírez, MF. Medina-Pérez, M. Rodríguez-Violante, R. Baños-Betancourt, A. Abundes-Corona, SF. Arechavala Lopez, WF. Moguel-Cardín ()

    Objective: To determine the impact of gastrointestinal symptoms on NMF in PD among Mexican individuals living with PD (PwP). Background: The growing interest in the…
  • 2024 International Congress

    Personality of Parkinson’s disease patients may influence the development and evolution of non-motor fluctuations

    M. Boussac, F. Faggianelli, E. Harroch, A. Eusebio, M. Fabbri, F. Ory-Magne, E. Descamps, O. Rascol, C. Laurencin, AR. Marques, M. Anheim, B. Giordana, L. Hopes, C. Moreau, AS. Rolland, D. Devos, D. Maltete, S. Ansquer, E. Hainque, S. Drapier, JP. Brandel, T. Rouaud, D. Guehl, B. Jarraya, M. Tir, T. Witjas, JP. Azulay, C. Brefel-Courbon (Toulouse, France)

    Objective: to evaluate the impact of personality on non-motor fluctuations (NMFs) in Parkinson’s disease (PD) and on NMFs evolution after dopaminergic treatments or deep brain…
  • 2024 International Congress

    When Off Can Cost Life: Myocardial Infarction Due to Spontaneous Coronary Dissection as a Catastrophic Manifestation in Advanced Parkinson’s Disease.

    S. Poveda, T. Lopez, B. Pascual Sedano, A. Campolongo (Bogotá, Colombia)

    Objective: Describe a patient with PD who suffered an acute myocardial infarction during a severe OFF period. Background: Advanced PD is characterized by complications including…
  • 2024 International Congress

    Criteria Defining Chronic Pain Associated with Parkinson Disease

    S. Perez-Lloret, J. Hunger, J. Bally, G. Kägi, J. Möller, N. Hollenstein, R. Gonzenbach, F. Brugger, D. Ciampi-de-Andrade, V. Mylius (Buenos Aires, Argentina)

    Objective: To assess the factors defining the association of chronic pain (>3 months) with PD. Background: Non-motor symptoms can be often associated with Parkinson disease…
  • 2024 International Congress

    Uncovering Patient Perspectives on Parkinson’s Disease to Inform Individualized Care

    A. Di Rocco, M. Armstrong, J. Carter, C. Chadha, K. Olson, L. Simone, L. Jarzylo (New York, USA)

    Objective: To gather patient insights on the burden of Parkinson’s disease (PD), understand the level of patient involvement in treatment decision-making, and determine overall satisfaction…
  • 2024 International Congress

    AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease

    SB. Soumma, D. Peterson, H. Ghasemzadeh, S. Mehta (Tempe, USA)

    Objective: This study developed a novel patient-independent, cost-effective AI model for detecting Freezing of Gait (FoG), using a single wearable sensor and without the need…
  • 2024 International Congress

    A Comparative Bioavailability Study between a Marketed Capsule-based Levodopa Dry Powder Inhaler and a New Pre-filled Levodopa Dry Powder Inhaler

    T. van Laar, F. Grasmeijer, M. Hoppentocht (Groningen, Netherlands)

    Objective: The primary objective was to determine the comparative bioavailability between a marketed and a new levodopa dry powder inhaler (DPI) with an enhanced usability…
  • 2024 International Congress

    Clinical benefit of Opicapone in patients with different Parkinson disease phenopytes. The OPTIMO study

    MR. Luquin, C. Martin, I. Tegel, I. Pijuan, C. Moreno (Pamplona, Spain)

    Objective: To assess the clinical benefit induced by opicapone (OPC) as an add-on therapy to levodopa in fluctuating Parkinson’s disease (PD) patients with special focus…
  • 2024 International Congress

    Efficacy and Safety of Amantadine in Parkinson’s Disease with Dyskinesia and Motor Fluctuations: A Systematic Review and Meta-Analysis

    S. Rujirussawarawong, S. Aungsumart, C. Kasemsuk, N. Limotai (Bangkok, Thailand)

    Objective: To evaluate the efficacy and safety of oral amantadine (AMA) compared to placebo in the treatment of dyskinesia (DYS) and motor fluctuations (MF) in…
  • 1
  • 2
  • 3
  • …
  • 24
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Patients with Essential Tremor Live Longer than their Relatives
  • Welcome to the MDS Abstracts Site
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley